Assessment of the Impact of Chemotherapeutic‘Treatment Effect’ on Oncological Outcomes in InitiallyNode‐Positive Breast Cancer Patients UndergoingSentinel Lymph Node Biopsy Only After NeoadjuvantChemotherapy Por [email protected] Assessment of the Impact of Chemotherapeutic‘Treatment Effect’ on Oncological Outcomes in InitiallyNode‐Positive Breast Cancer Patients UndergoingSentinel Lymph Node Biopsy Only After NeoadjuvantChemotherapy Read More »
Surgical Management of Young Women with High‑Risk Breast CancerReceiving Neoadjuvant Systemic Therapy on the I‑SPY2 Trial Por [email protected] Surgical Management of Young Women with High‑Risk Breast CancerReceiving Neoadjuvant Systemic Therapy on the I‑SPY2 Trial Read More »
Pathologic Complete Response (pCR) Rate and Predictors ofResponse to Taxane, Trastuzumab, and Pertuzumab inHER2‑Positive Breast Cancer: Secondary Analyses ofEA1181/CompassHER2 pCR Por [email protected] Pathologic Complete Response (pCR) Rate and Predictors ofResponse to Taxane, Trastuzumab, and Pertuzumab inHER2‑Positive Breast Cancer: Secondary Analyses ofEA1181/CompassHER2 pCR Read More »
Role of tumor-infiltrating lymphocytes in earlystage triple-negative breast cancer treated withKEYNOTE-522 in real-world setting Por [email protected] Role of tumor-infiltrating lymphocytes in earlystage triple-negative breast cancer treated withKEYNOTE-522 in real-world setting Read More »
Ovarian Reserve as a Measure of Adjuvant ChemotherapyBenefit in Hormone Receptor Positive (HR+), HER2-negative,Node-positive Breast Cancer in SWOG S1007 (RxPONDER) Por [email protected] Ovarian Reserve as a Measure of Adjuvant ChemotherapyBenefit in Hormone Receptor Positive (HR+), HER2-negative,Node-positive Breast Cancer in SWOG S1007 (RxPONDER) Read More »
HER2Δ16 directs luminal cell identity andestrogen receptor signaling in HER2+breast cancer Por [email protected] HER2Δ16 directs luminal cell identity andestrogen receptor signaling in HER2+breast cancer Read More »
Effect of exercise based prehabilitation on postoperative pain inbreast cancer patients: a systematic review with meta-analysi Por [email protected] Effect of exercise based prehabilitation on postoperative pain inbreast cancer patients: a systematic review with meta-analysi Read More »
Dalpiciclib plus endocrine therapy in women with HR+/HER2− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial Por [email protected] Dalpiciclib plus endocrine therapy in women with HR+/HER2− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial Read More »
Evolution of Axillary Surgical Management of Patients with OccultBreast Cancer with Axillary Metastasis Por [email protected] Evolution of Axillary Surgical Management of Patients with OccultBreast Cancer with Axillary Metastasis Read More »
GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults Por [email protected] GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults Read More »
Association between chemotherapy use and prognosis in young patientswith stage I-II ER+/HER2-negative breast cancer according to Prosigna®:An international real-world analysis with propensity-score matching Por [email protected] Association between chemotherapy use and prognosis in young patientswith stage I-II ER+/HER2-negative breast cancer according to Prosigna®:An international real-world analysis with propensity-score matching Read More »
Cryoablation for early-stage invasive breastcancer: pathologic and imaging outcomes fromthe prospective FIRST trial Por [email protected] Cryoablation for early-stage invasive breastcancer: pathologic and imaging outcomes fromthe prospective FIRST trial Read More »
